Maravai LifeSciences (MRVI)

Maravai LifeSciences stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology · NASDAQ

$8.26▲ +8.97%

Prices as of Oct 27, 2026 · USD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

46%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Maravai LifeSciences in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Maravai LifeSciences

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Maravai LifeSciences a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between $7.09 and $9.26; in 9 out of 10, between $5.60 and $11.72. Estimated annual volatility is 81%.

Price, last 12 months (weekly close)

Key numbers

52-week high: $9.42
52-week low: $2.55
Revenue (12 months): $209M
Revenue growth (YoY): -28.3%
Gross margin: 18.3%
Operating margin: -69.2%
Net margin: -124.2%
Return on equity: -33.1%
Free cash flow (12 months): $-3.6M
Beta: 0.61

What this means

ATLAS does not publish a fair value for MRVI right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks MRVI has traded between $2.55 and $9.42. Today it is 12.3% below that high and 224% above its low.

On the business: revenue fell 28.3% year over year; net margin is 124.2%.

Its beta is 0.61: it tends to move less than the market.

About the company

Maravai LifeSciences Holdings, Inc. Class A Common Stock represents ownership in Maravai LifeSciences Holdings, Inc., a life sciences company focused on products and services that support drug development, vaccine creation, cell and gene therapy research, and diagnostics.

Want to see everything about Maravai LifeSciences?

Get started →

Plans from €3.99 a month.

Frequently asked questions

What does Maravai LifeSciences do?

What is the chance MRVI goes up next month?

46%: close to a coin flip. In half of the simulated outcomes, MRVI ends the month between $7.09 and $9.26.

How volatile is MRVI?

ATLAS estimates annual volatility at 81%. In a typical month, half of the outcomes end between $7.09 and $9.26.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer